Analysis of genetic alterations in rectal cancer: Differences as compared with colon cancer;Analyse des alterations genetiques du cancer du rectum: Differences par rapport au cancer du colon

Gastroenterologie Clinique et Biologique

Volumn 22, Issue 8-9, 1998, Pages 679-687

  Rebischung, Christine ^a   Laurent Puig, Pierre ^a   Gerard, Jean Pierre ^b   Thomas, Gilles ^a   Hamelin, Richard ^a  

^a FONDATION JEAN DAUSSET CEPH   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Cancer; LOH type; Rectum; RER type

Indexed keywords

NUCLEOTIDE; PROTEIN P53; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; COLON CANCER; COLON POLYPOSIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; FEMALE; GENE MUTATION; GENETIC DISORDER; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; ONCOGENE K RAS; PHENOTYPE; RECTUM CANCER; COLON TUMOR; COMPARATIVE STUDY; GENETICS; GENOTYPE; MIDDLE AGED; ONCOGENE RAS; RECTUM TUMOR; TUMOR SUPPRESSOR GENE;

AGED; COLONIC NEOPLASMS; FEMALE; GENES, APC; GENES, P53; GENES, RAS; GENOTYPE; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHENOTYPE; RECTAL NEOPLASMS;

EID: 0032147611     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Faivre J, Grosclaude P, Launoy G, Arveux P, Raverdy N, Menegoz F, et al. Les cancers digestifs en France. Distribution géographique et estimation de l'incidence nationale. Gastroenterol Clin Biol 1997;21:174-80.
2. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, et al. Microsatellite instability and mutations of the transforming growth factor ß type II receptor gene in colorectal cancer. Cancer Res 1995;55 5548-50.
3. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
4. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
5. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 1996;2:169-74.
6. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-3.
7. Cremonesi L, Firpo M, Ferrari M, Righetti PG, Gelfi C. Double-gradient DGGE for optimized detection of DNA point mutations. Biotechniques 1997;22:326-30.
8. Hamelin R, Jego N, Laurent-Puig P, Vidaud M, Thomas G. Efficient screening of p53 mutations by denaturing gradient gel electropho-resis in colorectal tumors. Oncogene 1993;8:2213-20.
9. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci USA 1997;94:12122-7.
10. Powell SM, Petersen GM, Krush AJ, Booker S, Jen J, Giardiello FM, et al. Molecular diagnosis of familial adenomatous polyposis. N Eng J Med 1993;329:1982-7.
11. Bos JL, Fearon ER, Hamilton SR, Verlaan-de Vries M, Van Boom JH, Van der Eb AJ, et al. Prevalence of ras gene mutations in human colorectal cancers. Nature 1987;327:293-7.
12. Laurent-Puig P, Delattre O, Olschwang S, Remvikos Y, Melot T, Salmon RJ, et al. Etude conjointe des mutations de l'oncogène Ki-Ras et de la surexpression de l'oncogène Tp53 dans les cancers colorectaux. Gastroenterol Clin Biol 1990;14:347-51.
13. Lynch HT, Smyrk TC, Watson P, Lanspa SJ, Lynch JF, Lynch PM, et al. Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 1993;104:1535-49.
14. Aaltonen LA, Peltomäki P, Leach FS, Sistonen P, Pylkkänen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
15. Peltomäki P, Lothe RA, Aaltonen LA, Pylkkänen L, Nyström-Lahti M, Seruca R, et al. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res 1993;53:5853-5.
16. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
17. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
18. Zhou XP, Hoang JM, Cottu PH, Thomas G, Hamelin R. Allelic profiles of mononucleotide repeat microsatellites in control individuals and in colorectal tumors with and without replication errors. Oncogene 1997;15:1713-8.
19. Zhou XP, Hoang JM, Li YJ, Seruca R, Carneiro F, Sobrinho-Simoes M, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-7.
20. Markowitz S, Wang J, Myeroff L, Parsons R, Sun LZ, Lutterbaugh J, et al. Inactivation of the type II TGF ß receptor in colon cancer cells with microsatellite instability. Science 1995;268:1336-8.
21. Kim H, Jen J, Vogelstein B, Hamilton SR. Clinical and pathological characteristics of sporadic colorectal carcinomas with DNA replication errors in microsatellile sequences. Am J Pathol 1994;145:148-56.
22. Cottu PH, Muzeau F, Estreicher A, Fléjou JF, Iggo R, Thomas G, et al. Inverse correlation between RER + status and p53 mutation in colorectal cancer cell lines. Oncogene 1996;13:2727-30.
23. Hamelin R, Laurent-Puig P. p53 et cancers colorectaux. Pathol Biol (Paris). 1998;45:876-81.
24. Hamelin R, Laurent-Puig P, Olschwang S, Jego N, Asselain B, Remvikos Y, et al. Association of p53 mutations with short survival in colorectal cancer. Gastroenterology 1994;106:42-8.
25. Greenblatl MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-78.
26. Rideout WM, Coetzee GA, Olumi AF, Jones PA. 5-methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science 1990;249:1288-90.
27. Béroud C, Soussi T. p53 gene mutation: software and database. Nucl Acid Res 1998;26:202-7.
28. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992;359:235-7.
29. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JKV. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993;90:2846-50.
30. Miyaki M, Konishi M, Kikuchi-Yanoshita R, Enomoto M, Igari T, Tanaka K, et al. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors. Cancer Res 1994;54:3011-20.
31. Rubinfeld B, Souza B, Albert I, Müller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with B-catenin. Science 1993;262:1731-3.
32. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993;262:1734-7.
33. Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler K, et al. Constitutive transcriptional activation by a ß-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7.
34. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, et al. Activation of ß-catenin-Tcf signaling in colon cancer by mutations in ß-catenin or APC. Science 1997;275:1787-90.
35. Forrester K, Almoguera C, Han K, Grizzle WE, Perucho M. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature 1987;327:298-303.
36. Bos J. Ras oncogenes in human cancer : a review. Cancer Res 1989;49:4682-9.
37. Burmer GC, Loeb LA. Mutations in the K-Ras2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA 1989;86:2403-7.